Ozurdex® (dexamethasone) Implant Risk Management Plan Injector's Guide Assessment Australia

04/06/2018
01/04/2024
EU PAS number:
EUPAS23093
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

OZURDEX_AUSTRALIA_RMP_ASA_v5.3_RVO-DME-Uveitis_May2017_Redacted

English (1.22 MB - PDF) View document
Study results
Study results

Ozurdex RMP REPORT FINAL_29Jan18_clean_v3.0_Redacted

English (464.61 KB - PDF) View document
Study report
Other information